6th
August 2019 – Global Research Antibodies Market size is
expected to reach USD 4.30 billion by 2025. Antibodies are secreted
immunoglobin molecules mainly produced by plasma cells. They are a part of the
body’s immune system. The normal function of antibodies is to latch onto
antigens and flag them for destruction, thus helping to fight infection. The
market is driven by increasing R&D collaborations among various private
& public organizations to promote technical advancements in disease
progression and product development activities. The market size is expected to
expand at a CAGR of 6.1% in the upcoming period.
In research antibodies, some technologies are used such
as Immunohistochemistry, Western Blotting, Immunofluorescence,
Immunoprecipitation, Flow Cytometry, ELISA, and others. The “western blotting”
segment held largest market share in 2016 and is expected to hold the highest
market share in the upcoming period due to growing prevalence of diseases with
limited treatment options such as HIV. Western blotting is used in research
activities conducted by pharmaceutical & biotechnology companies as well as
academic institutes.
Product type such as primary and secondary could be
explored in research antibodies industry. Primary antibodies were the most
leading product type in 2016 due to greater specificity leading to increased
adoption in research activities. The segment is anticipated to grow at the
highest CAGR during the forecast period owing to the increasing adoption of
reagents containing primary research antibodies due to its related benefits such
as greater specificity, easy availability and suitability to various research
needs.
Get a Sample Copy
of This Report @ https://www.millioninsights.com/industry-reports/research-antibodies-market/request-sample
The factors that play an important role in the growth of
research antibodies market include increasing demand, growing population,
increasing urbanization & industrialization, increasing funding for
proteomics research & drug discovery, growing R&D activities &
expenditure in the life science industry, increasing demand for personalized
medicine & protein therapeutics, technological advancements and stringent
government rules & regulations. Moreover, increasing prevalence of breast
cancer and rising need for personalized medicine is stirring up the demand for
advanced techniques, which is creating ample growth of the market.
However, the quality concerns over research antibodies,
time & cost intensive antibody development processes and the pricing
pressures faced by market players are negatively impacting the growth of
research antibodies industry. The market is widely analyzed based on different
regional factors such as gross domestic product (GDP), demographics,
acceptance, inflation rate and others. The market is categorized based on
product, type, technology, source, application, end-use and geography.
The market is classified into type such as monoclonal
antibodies, polyclonal antibodies, and others. The “monoclonal antibodies”
accounted for the leading share in 2016 and is anticipated to grow at a high
CAGR in the next couple of years. Significantly rising number of research
activities in genomics that require technologically advanced genetic platforms
has led to increase the demand for monoclonal antibodies.
North America held largest market share in 2016 due to
presence of many biopharmaceutical & biotechnology manufacturers and
academic institutes coupled with huge economic development. Asia Pacific is
expected to hold the highest market share in the forthcoming years. The growing
population, booming healthcare industry, increasing innovation in antibody
production and improving healthcare infrastructure coupled with regulatory
policies implemented by public healthcare organizations to enhance safety are
major factors driving the growth of the market in this region.
The key players contributing to the robust development of
the research antibodies market include Abcam PLC, Agilent Technologies, Thermo
Fisher Scientific Inc., Merck Group, Becton, Dickinson and Company, Cell
Signaling Technology Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd,
GenScript, Danaher Corporation, PerkinElmer Inc., Genscript, BioLegend Inc. and
Lonza. These market players are focusing on inorganic growth to sustain
themselves amidst fierce competition. As such, mergers, acquisitions, and joint
ventures are the need of the hour.
For More Details,
Visit @ http://www.millioninsights.com
No comments:
Post a Comment